基本信息
views: 7
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Vanessa is highly experienced in the molecular study of cancer risk factors, cancer genomics and cancer cell biology.
She moved to the QIMR Berghofer Medical Research Institute, Brisbane, where she focused on elucidating the genetic changes driving melanoma progression and resistance to treatment. She specialised in understanding the impact of epigenetics, methylation and miRNA expression during melanomagenesis. In 2015, Vanessa joined the Translational Research Institute where she developed patient derived xenograft mice models of endometrial cancer. She focused on evaluating the efficacy of combination therapies by repurposing approved chemotherapies and targeted therapies for endometrial cancer.
Since 2018, Vanessa has coordinated the Cancer Evolution Biobank which collects samples from patients with melanoma, oesophageal/gastric cancer and pancreatic cancer. Her current research focuses on developing blood biomarkers for predicting therapy response and survival. Overall, she contributes to the development of precision medicine to inform treatment decisions and improve health outcomes for patients with melanoma, oesophago-gastric cancer and pancreatic cancer.
She moved to the QIMR Berghofer Medical Research Institute, Brisbane, where she focused on elucidating the genetic changes driving melanoma progression and resistance to treatment. She specialised in understanding the impact of epigenetics, methylation and miRNA expression during melanomagenesis. In 2015, Vanessa joined the Translational Research Institute where she developed patient derived xenograft mice models of endometrial cancer. She focused on evaluating the efficacy of combination therapies by repurposing approved chemotherapies and targeted therapies for endometrial cancer.
Since 2018, Vanessa has coordinated the Cancer Evolution Biobank which collects samples from patients with melanoma, oesophageal/gastric cancer and pancreatic cancer. Her current research focuses on developing blood biomarkers for predicting therapy response and survival. Overall, she contributes to the development of precision medicine to inform treatment decisions and improve health outcomes for patients with melanoma, oesophago-gastric cancer and pancreatic cancer.
Research Interests
Papers共 67 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Genome Medicineno. 1 (2024): 1-16
crossref(2023)
The Journal of Molecular Diagnosticsno. 10 (2023): 771-781
Jonathan R. Dry,Sandra Pavey, Christine A. Pratilas, Chris Harbron,Sarah Runswick,Darren Hodgson,Christine Chresta,Rose McCormack,Natalie Byrne,Mark Cockerill,Alexander Graham,Garry Beran,
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Asia-Pacific journal of clinical oncology (2023)
crossref(2023)
Load More
Author Statistics
#Papers: 68
#Citation: 3509
H-Index: 16
G-Index: 27
Sociability: 6
Diversity: 2
Activity: 23
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn